ClinicalTrials.Veeva

Menu
M

Meclinas | Mechelen, Belgium

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Brenipatide
Eloralintide
LY3841136
Empagliflozin
Muvalaplin
BI 690517
Vicadrostat
Alcohol
Iclepertin
iclepertin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 13 total trials

A Study of Brenipatide in Participants With Alcohol Use Disorder (RENEW-ALC-2)

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and...

Enrolling
Alcohol Use Disorder
Drug: Placebo
Drug: LY3537031

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use...

Enrolling
Alcohol Use Disorder
Drug: LY3537031
Drug: Placebo
New

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity o...

Begins enrollment this month
Overweight
Obesity
Drug: Placebo
Drug: Eloralintide

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2...

Begins enrollment this month
Obesity
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Placebo
Drug: Muvalaplin
Locations recently updated

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

The subjects will use study product twice daily for 8 weeks starting at Visit 1. The recommendation is to consume one serving in the morning and one...

Enrolling
Disease Related Malnutrition
Dietary Supplement: Test Product: Plant based high energy high protein ONS
Dietary Supplement: Control Product: Dairy based high energy high protein ONS

The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralint...

Not yet enrolling
Overweight or Obesity
Osteoarthritis
Drug: Placebo
Drug: Eloralintide

The goal of this prospective, monocentric, open-label, non-randomized and single arm study is to evaluate a reduction of migraine days per months (MD...

Enrolling
Migraine in Adults
Migraine Headache
Dietary Supplement: Neuro-Complex and Multi

Trial sponsors

Lilly logo
Boehringer Ingelheim logo
Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo
Nutricia logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems